94 related articles for article (PubMed ID: 24193002)
1. Frequent PIK3CA mutations in radial scars.
Wolters KL; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML
Diagn Mol Pathol; 2013 Dec; 22(4):210-4. PubMed ID: 24193002
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma.
Flatley E; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2013 Jul; 44(7):1320-7. PubMed ID: 23352210
[TBL] [Abstract][Full Text] [Related]
3. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
Kehr EL; Jorns JM; Ang D; Warrick A; Neff T; Degnin M; Lewis R; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2012 Dec; 43(12):2207-12. PubMed ID: 22705004
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions.
Troxell ML; Brunner AL; Neff T; Warrick A; Beadling C; Montgomery K; Zhu S; Corless CL; West RB
Mod Pathol; 2012 Jul; 25(7):930-7. PubMed ID: 22460814
[TBL] [Abstract][Full Text] [Related]
5. Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing.
Ang D; O'Gara R; Schilling A; Beadling C; Warrick A; Troxell ML; Corless CL
J Mol Diagn; 2013 May; 15(3):312-8. PubMed ID: 23541593
[TBL] [Abstract][Full Text] [Related]
6. Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.
Ramirez-Ardila DE; Helmijr JC; Look MP; Lurkin I; Ruigrok-Ritstier K; van Laere S; Dirix L; Sweep FC; Span PN; Linn SC; Foekens JA; Sleijfer S; Berns EM; Jansen MP
Breast Cancer Res Treat; 2013 May; 139(1):39-49. PubMed ID: 23592373
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.
Dunlap J; Le C; Shukla A; Patterson J; Presnell A; Heinrich MC; Corless CL; Troxell ML
Breast Cancer Res Treat; 2010 Apr; 120(2):409-18. PubMed ID: 19418217
[TBL] [Abstract][Full Text] [Related]
9. Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.
Harlé A; Lion M; Lozano N; Husson M; Harter V; Genin P; Merlin JL
Oncol Rep; 2013 Mar; 29(3):1043-52. PubMed ID: 23314198
[TBL] [Abstract][Full Text] [Related]
10. Radial scars in benign breast-biopsy specimens and the risk of breast cancer.
Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ
N Engl J Med; 1999 Feb; 340(6):430-6. PubMed ID: 9971867
[TBL] [Abstract][Full Text] [Related]
11. The treatment of radial scars in the modern era--surgical excision is not required.
Sohn VY; Causey MW; Steele SR; Keylock JB; Brown TA
Am Surg; 2010 May; 76(5):522-5. PubMed ID: 20506884
[TBL] [Abstract][Full Text] [Related]
12. FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo.
Hafner C; Stoehr R; van Oers JM; Zwarthoff EC; Hofstaedter F; Landthaler M; Hartmann A; Vogt T
Br J Dermatol; 2009 Mar; 160(3):546-51. PubMed ID: 19076977
[TBL] [Abstract][Full Text] [Related]
13. High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
Nichols AC; Palma DA; Chow W; Tan S; Rajakumar C; Rizzo G; Fung K; Kwan K; Wehrli B; Winquist E; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):617-22. PubMed ID: 23787421
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Takano M; Iwaya K; Tamai S; Matsubara O
J Pathol; 2011 Oct; 225(2):189-94. PubMed ID: 21735444
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs.
Ross RL; Askham JM; Knowles MA
Oncogene; 2013 Feb; 32(6):768-76. PubMed ID: 22430209
[TBL] [Abstract][Full Text] [Related]
16. FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra.
Hafner C; Landthaler M; Mentzel T; Vogt T
Br J Dermatol; 2010 Mar; 162(3):508-12. PubMed ID: 19845664
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk in women with radial scars in benign breast biopsies.
Berg JC; Visscher DW; Vierkant RA; Pankratz VS; Maloney SD; Lewis JT; Frost MH; Ghosh K; Degnim AC; Brandt KR; Vachon CM; Reynolds CA; Hartmann LC
Breast Cancer Res Treat; 2008 Mar; 108(2):167-74. PubMed ID: 18297395
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
19. Radial scars in women with breast cancer.
Nielsen M; Christensen L; Andersen J
Cancer; 1987 Mar; 59(5):1019-25. PubMed ID: 3815261
[TBL] [Abstract][Full Text] [Related]
20. Myofibroblast activity of radial scars.
Battersby S; Anderson TJ
J Pathol; 1985 Sep; 147(1):33-40. PubMed ID: 2931506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
